Risk of venous thromboembolism with the use of oral contraceptives
An association between oral contraceptive use and venous thromboembolism (VTE) appears to exist, but the reported risk is probably exaggerated. The users of non-third-generation OCs have a less than 3-fold increase in risk for VTE compared to nonusers: the risk for VTE is possibly higher in users of third-generation OCs.
Do you want to read more?
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.